Nagase : Announcement of Transfer of Shares of Nagase Medicals Co. Ltd
September 01, 2020 at 07:48 am EDT
Share
NAGASE & CO., LTD. (Chuo-ku, Tokyo; Representative Director and President: Kenji Asakura, hereafter 'Nagase & Co.') has decided to transfer all held shares of Nagase Medicals Co., Ltd. (Itami, Hyogo; Representative Director and President: Mitsuru Akasaka), a consolidated subsidiary of NAGASE that is engaged in the development and manufacture of pharmaceuticals, to Shionogi Pharma Co., Ltd. (Settsu, Osaka Pref.; Representative Director and President: Ryuichi Kume), a wholly-owned subsidiary of Shionogi & Co., Ltd. (Chuo-ku, Osaka; Representative Director and President: Isao Teshirogi).
Based on the manufacturing technology of sterile formulations and highly active formulations, Nagase Medicals has proceeded with a business structure reform in order to strengthen the company's competitive advantage in the contract manufacturing of injections and the development of its proprietary generic drugs. Under these circumstances, Nagase & Co. has negotiated with Shionogi Pharma, which focuses on the contract development and manufacturing organization (CDMO) business and aims to become an industry leader in highly potent injectables and active solid formulations. After examining a variety of possible options, the two companies have come to agree that the transfer of shares would lead to further growth of both Shionogi Pharma and Nagase Medicals. Equipped with GMP (Good Manufacturing Practice)-compliant injectable production facility, Nagase Medicals will continue its business at its present location, mainly as a manufacturing base for highly active injectable drug.
The shares of Nagase Medicals will be transferred but Nagase & Co. will continue to actively engage in the pharmaceutical business (distribution of formulations, APIs, intermediates, raw materials, and APIs for generic drugs, etc.), as well as the pharma medical business including the development of software in the medical imaging field. With life and healthcare positioned as one of its focus areas, Nagase & Co. will continue to select and concentrate its businesses in order to increase corporate value by creating synergies within the NAGASE Group.
Nagase & Co Ltd is a Japan-based company mainly engaged in the import, export, manufacture and sale of a wide range of products. The Company operates through five business segments. Functional Materials segment offers raw materials for paints, inks, adhesives, and other products. Processed Materials segment offers dyes, pigments, functional pigments, resins, automotive repair and conductive paints and others. Electronics and Energy segment offers modified epoxy resins, fluorine products, and materials and equipment for semiconductor, display, as well as energy management system proposals, battery evaluation and healthcare services. Mobility segment offers general synthetic resins, and other materials and parts for automobile. Life-related segment offers raw materials for pharmaceuticals and agrochemicals, food additive, cosmetic additives, and radiation measurement service. The Company also offers logistics services, information processing and other professional services.
NAGASE & CO., LTD. 
